Alight Introduces GLP-1 HRA Solution to Help Employers Manage Access, Affordability and Cost
DEERFIELD, Ill.--(BUSINESS WIRE)--Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth and leave solutions, today announced a new health reimbursement account (HRA) that helps employers offer financial support to their employees for eligible GLP-1 medications, while enabling more control over program costs and design.The Alight GLP-1 HRA gives employers another way to support employees as they incorporate GLP-1 medications into their broader health and benefits.